HOOKIPA Pharma Inc. 4 SEC Filings

Filed On	Filing
09 Oct 2025	Form 4: Peters Malte, Director Sold 25,172 shares ($20.7K)
23 Jul 2025	Form 4: Peters Malte, Director Sold 29,176 shares ($26.8K)
23 Jul 2025	Form 4: Coelho Mary Theresa, Director Sold 13,609 shares ($12.5K)
24 Jul 2024	Form 4: Coelho Mary Theresa, Director Received 69,875 shares as a grant or award
24 Jul 2024	Form 4: Peters Malte, Director Received 108,695 shares as a grant or award
24 Jul 2024	Form 4: Cassidy Sean A, Director Granted 9,800 Stock Option (Right to Buy)
18 Jun 2024	Form 4: van de Winkel Jan, Director Granted 98,000 Stock Option (Right to Buy)
18 Jun 2024	Form 4: Peters Malte, Director Granted 49,000 Stock Option (Right to Buy)
18 Jun 2024	Form 4: Kaufman David Ross, Director Granted 49,000 Stock Option (Right to Buy)
18 Jun 2024	Form 4: O'Neill Julie, Director Granted 49,000 Stock Option (Right to Buy)
18 Jun 2024	Form 4: Coelho Mary Theresa, Director Granted 49,000 Stock Option (Right to Buy)
18 Jun 2024	Form 4: Reilly Timothy P., Director Granted 49,000 Stock Option (Right to Buy)
17 Apr 2024	Form 4: Orlinger Klaus, Chief Scientific Officer Granted 367,300 Stock Option (Right to Buy)
17 Apr 2024	Form 4: Aldag Jorn, Director Granted 971,400 Stock Option (Right to Buy)
17 Apr 2024	Form 4: Winderlich Mark, Chief Development Officer Granted 300,000 Stock Option (Right to Buy)
17 Apr 2024	Form 4: Kandera Reinhard, Director Granted 406,200 Stock Option (Right to Buy)
17 Apr 2024	Form 4: Necina Roman, Chief Operations Officer Granted 367,300 Stock Option (Right to Buy)
22 Aug 2023	Form 4: Kandera Reinhard, Director Bought 7,000 shares ($5.08K)
17 Aug 2023	Form 4: Kandera Reinhard, Director Bought 8,000 shares ($5.71K)
11 Jul 2023	Form 4: Aldag Jorn, Director Bought 5,000 shares ($4.05K) · Bought 5,000 shares ($4.14K)

Comments